These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 29032374)

  • 1. The ALPPS Approach for Colorectal Liver Metastases: Impact of KRAS Mutation Status in Survival.
    Serenari M; Alvarez FA; Ardiles V; de Santibañes M; Pekolj J; de Santibañes E
    Dig Surg; 2018; 35(4):303-310. PubMed ID: 29032374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of KRAS and BRAF Mutations on Survival of Metastatic Colorectal Cancer After Liver Resection: A Systematic Review and Meta-Analysis.
    Tosi F; Magni E; Amatu A; Mauri G; Bencardino K; Truini M; Veronese S; De Carlis L; Ferrari G; Nichelatti M; Sartore-Bianchi A; Siena S
    Clin Colorectal Cancer; 2017 Sep; 16(3):e153-e163. PubMed ID: 28216246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Associating liver partition and portal vein ligation for staged hepatectomy in patients with colorectal liver metastases--Intermediate oncological results.
    Björnsson B; Sparrelid E; Røsok B; Pomianowska E; Hasselgren K; Gasslander T; Bjørnbeth BA; Isaksson B; Sandström P
    Eur J Surg Oncol; 2016 Apr; 42(4):531-7. PubMed ID: 26830731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival after associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) for advanced colorectal liver metastases: A case-matched comparison with palliative systemic therapy.
    Olthof PB; Huiskens J; Wicherts DA; Huespe PE; Ardiles V; Robles-Campos R; Adam R; Linecker M; Clavien PA; Koopman M; Verhoef C; Punt CJ; van Gulik TM; de Santibanes E
    Surgery; 2017 Apr; 161(4):909-919. PubMed ID: 28038862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association Between Specific Mutations in KRAS Codon 12 and Colorectal Liver Metastasis.
    Margonis GA; Kim Y; Spolverato G; Ejaz A; Gupta R; Cosgrove D; Anders R; Karagkounis G; Choti MA; Pawlik TM
    JAMA Surg; 2015 Aug; 150(8):722-9. PubMed ID: 26038887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resection of Colorectal Liver Metastasis: Prognostic Impact of Tumor Burden vs KRAS Mutational Status.
    Tsilimigras DI; Hyer JM; Bagante F; Guglielmi A; Ruzzenente A; Alexandrescu S; Poultsides G; Sasaki K; Aucejo F; Pawlik TM
    J Am Coll Surg; 2021 Apr; 232(4):590-598. PubMed ID: 33383214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy in the Treatment of Colorectal Liver Metastases: Current Scenario.
    Lang H; Baumgart J; Mittler J
    Dig Surg; 2018; 35(4):294-302. PubMed ID: 29621745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can we improve the morbidity and mortality associated with the associating liver partition with portal vein ligation for staged hepatectomy (ALPPS) procedure in the management of colorectal liver metastases?
    Hernandez-Alejandro R; Bertens KA; Pineda-Solis K; Croome KP
    Surgery; 2015 Feb; 157(2):194-201. PubMed ID: 25282528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Indicating ALPPS for Colorectal Liver Metastases: A Critical Analysis of Patients in the International ALPPS Registry.
    Schnitzbauer AA; Schadde E; Linecker M; Machado MA; Adam R; Malago M; Clavien PA; de Santibanes E; Bechstein WO
    Surgery; 2018 Sep; 164(3):387-394. PubMed ID: 29803563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of BRAF Mutations With Survival and Recurrence in Surgically Treated Patients With Metastatic Colorectal Liver Cancer.
    Margonis GA; Buettner S; Andreatos N; Kim Y; Wagner D; Sasaki K; Beer A; Schwarz C; Løes IM; Smolle M; Kamphues C; He J; Pawlik TM; Kaczirek K; Poultsides G; Lønning PE; Cameron JL; Burkhart RA; Gerger A; Aucejo FN; Kreis ME; Wolfgang CL; Weiss MJ
    JAMA Surg; 2018 Jul; 153(7):e180996. PubMed ID: 29799910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of various RAS codon mutations and prognostic outcomes of patients with colorectal liver metastases after hepatectomy.
    Wu XG; Liu W; Wang YY; Wang K; Xing BC
    Cancer Med; 2024 Oct; 13(19):e70168. PubMed ID: 39377605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. KRAS Status as an Independent Prognostic Factor for Survival after Yttrium-90 Radioembolization Therapy for Unresectable Colorectal Cancer Liver Metastases.
    Lahti SJ; Xing M; Zhang D; Lee JJ; Magnetta MJ; Kim HS
    J Vasc Interv Radiol; 2015 Aug; 26(8):1102-11. PubMed ID: 26210240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Operative Results and Oncologic Outcomes of Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy (ALPPS) Versus Two-Stage Hepatectomy (TSH) in Patients with Unresectable Colorectal Liver Metastases: A Systematic Review and Meta-Analysis.
    Moris D; Ronnekleiv-Kelly S; Kostakis ID; Tsilimigras DI; Beal EW; Papalampros A; Dimitroulis D; Felekouras E; Pawlik TM
    World J Surg; 2018 Mar; 42(3):806-815. PubMed ID: 28798996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjuvant Hepatic Artery Infusion Chemotherapy is Associated With Improved Survival Regardless of KRAS Mutation Status in Patients With Resected Colorectal Liver Metastases: A Retrospective Analysis of 674 Patients.
    Gholami S; Kemeny NE; Boucher TM; Gönen M; Cercek A; Kingham TP; Balachandran V; Allen P; DeMatteo R; Drebin J; Jarnagin W; D'Angelica M
    Ann Surg; 2020 Aug; 272(2):352-356. PubMed ID: 32675549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcome after associating liver partition and portal vein ligation for staged hepatectomy and conventional two-stage hepatectomy for colorectal liver metastases.
    Adam R; Imai K; Castro Benitez C; Allard MA; Vibert E; Sa Cunha A; Cherqui D; Baba H; Castaing D
    Br J Surg; 2016 Oct; 103(11):1521-9. PubMed ID: 27517369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anatomical Resections Improve Disease-free Survival in Patients With KRAS-mutated Colorectal Liver Metastases.
    Margonis GA; Buettner S; Andreatos N; Sasaki K; Ijzermans JNM; van Vugt JLA; Pawlik TM; Choti MA; Cameron JL; He J; Wolfgang CL; Weiss MJ
    Ann Surg; 2017 Oct; 266(4):641-649. PubMed ID: 28657938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strategies to Increase the Resectability of Patients with Colorectal Liver Metastases: A Multi-center Case-Match Analysis of ALPPS and Conventional Two-Stage Hepatectomy.
    Ratti F; Schadde E; Masetti M; Massani M; Zanello M; Serenari M; Cipriani F; Bonariol L; Bassi N; Aldrighetti L; Jovine E
    Ann Surg Oncol; 2015; 22(6):1933-42. PubMed ID: 25564160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intermediate-term survival and quality of life outcomes in patients with advanced colorectal liver metastases undergoing associating liver partition and portal vein ligation for staged hepatectomy.
    Wanis KN; Ardiles V; Alvarez FA; Tun-Abraham ME; Linehan D; de Santibañes E; Hernandez-Alejandro R
    Surgery; 2018 Apr; 163(4):691-697. PubMed ID: 29203284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Associating liver partition and portal vein ligation for staged hepatectomy (ALPPS): impact of the inter-stages course on morbi-mortality and implications for management.
    Truant S; Scatton O; Dokmak S; Regimbeau JM; Lucidi V; Laurent A; Gauzolino R; Castro Benitez C; Pequignot A; Donckier V; Lim C; Blanleuil ML; Brustia R; Le Treut YP; Soubrane O; Azoulay D; Farges O; Adam R; Pruvot FR;
    Eur J Surg Oncol; 2015 May; 41(5):674-82. PubMed ID: 25630689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of associating liver partition and portal vein ligation for staged hepatectomy in colorectal liver metastases: a review.
    Hasselgren K; Sandström P; Björnsson B
    World J Gastroenterol; 2015 Apr; 21(15):4491-8. PubMed ID: 25914457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.